AME Bioscience AS - Company Review
AME Bioscience AS - Company ReviewSummary
AME Bioscience A/S (AME Bioscience) is a provider of sanger sequencing reagents. The company's bioautomation synthesizers provides DNA and RNA Synthesizers such as mermade 4 synthesizer, mermade 6 synthesizer, mermade 12 synthesizer, and mermade 192 synthesizer. AME Bioscience’s nanostring products include ncounter workflow, ncounter analysis system, gene expression codesets, panel plus and codeset plus, single cell GX expression, plex2m for gene expression, miRNA assay, miRGE assay, CNV codesets, incRNA assay, chip string assay, leukemia fusion gene, and nsolver analysis software. The company has its presence in Norway, the UK, Denmark, Finland, Iceland, Sweden and Ireland. AME Bioscience is headquartered in Tonsberg, Norway.
This comprehensive company report of AME Bioscience AS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.